10-43113655-G-A

Variant summary

Our verdict is Pathogenic.
>+14 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 18 classification points (ACMG Germline Pathogenicity v2019). PS3PM1PM2PM5PP3_StrongPP5_Strong

The NM_020975.6(RET):c.1859G>A (p.Cys620Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 8.13). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000934750: Experimental studies have shown that this missense change affects RET function (PMID:9012462, 15472167)." and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.C620R: Pathogenic (ClinVar VariationId 13915, 2 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.C620= (synonymous): Conflicting_classifications_of_pathogenicity (ClinVar VariationId 549782) This exact variant is curated in the UniProt human variants database as Uncertain Significance.

Frequency

Genomes: not found (cov: 32)

Consequence

RET
NM_020975.6 missense

Scores

14
5

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:11

Conservation

PhyloP100: 8.13

Publications

17 publications found
Variant links:
Genes affected
RET (HGNC:9967): (ret proto-oncogene) This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017]
RET Gene-Disease associations (from GenCC):
  • familial medullary thyroid carcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • multiple endocrine neoplasia type 2A
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P
  • multiple endocrine neoplasia type 2B
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Hirschsprung disease, susceptibility to, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Haddad syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hirschsprung disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • bilateral renal agenesis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_020975.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 18 points.

PS3Functional studies show damaging effect
Well-established functional study supports damaging effect (PS3); SCV000934750: Experimental studies have shown that this missense change affects RET function (PMID: 9012462, 15472167).; SCV002771205: Assessment of experimental evidence suggests this variant results in abnormal protein function. This variant activates RET protein kinase transforming capability, thereby inducing the protein's oncogenic activation (PMID 9230192, 18248667, 15472167, 9012462).
PM1Mutational hot spot or critical domain
Missense neighbourhood hotspot (≥2 P/LP within ±8 AA, OR ≥ 5 vs. background) — PM1; In-domain: 0 pathogenic, 0 benign rare missense variants.; ±8 AA neighbourhood: 6 pathogenic, 2 benign (OR vs. background: 13.0).
PM2Absent/extremely low in population databases
Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD+AR) (base 0.0001, raised to 0.000122 by highest known P/LP ClinVar AF 0.000122) — PM2 moderate.
PM5Novel missense at known pathogenic residue
Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.C620R: Pathogenic (ClinVar VariationId 13915, 2 stars); Other variants at the same amino acid residue (not pathogenic): p.C620= (synonymous): Conflicting_classifications_of_pathogenicity (ClinVar VariationId 549782)
PP3Computational evidence supports damaging effect
Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — strong evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Strong).
PP5Reputable source reports pathogenic
ClinVar 2-star pathogenic — strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). ClinVar submissions strongly and reliably favor pathogenicity (11/11 total P/LP).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_020975.6. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

RET NM_020975.6
MANE Select
HGVSc / HGVSpc.1859G>Ap.Cys620Tyr
Exon rankExon 10 of 20
missense
Prot: NP_066124.1UniProt: P07949-1
RET NM_001406743.1
HGVSc / HGVSpc.1859G>Ap.Cys620Tyr
Exon rankExon 10 of 21
missense
Prot: NP_001393672.1UniProt: P07949-1
RET NM_001406744.1
HGVSc / HGVSpc.1859G>Ap.Cys620Tyr
Exon rankExon 10 of 20
missense
Prot: NP_001393673.1

Ensembl Transcripts

RET ENST00000355710.8
TSL:5MANE Select
HGVSc / HGVSpc.1859G>Ap.Cys620Tyr
Exon rankExon 10 of 20
missense
Prot: ENSP00000347942.3UniProt: P07949-1
RET ENST00000340058.6
TSL:1
HGVSc / HGVSpc.1859G>Ap.Cys620Tyr
Exon rankExon 10 of 19
missense
Prot: ENSP00000344798.4UniProt: P07949-2
RET ENST00000713926.1
HGVSc / HGVSpc.1730G>Ap.Cys577Tyr
Exon rankExon 10 of 19
missense
Prot: ENSP00000519223.1UniProt: A0AAQ5BH28

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
Cov:31
GnomAD4 genome
Cov:32
TOPMed (Bravo)
AF: 0.00000378
AC:1
Hom:0
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00
AC:0
Hom:0
AN:192272
Local & regional cohorts 1 source
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.00000800
AC:1
Hom:0
AN:122592
Showing 6 sources

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
5
-
-
not provided (5)
2
-
-
Multiple endocrine neoplasia type 2A (2)
1
-
-
Aganglionic megacolon (1)
1
-
-
Hereditary cancer-predisposing syndrome (1)
1
-
-
Multiple endocrine neoplasia type 2A;C0025269:Multiple endocrine neoplasia type 2B;C0031511:Pheochromocytoma;C1833921:Familial medullary thyroid carcinoma;C3888239:Hirschsprung disease, susceptibility to, 1 (1)
1
-
-
Multiple endocrine neoplasia, type 2 (1)

Computational Scores

AlphaGenome AVI
Pathogenic28
AlphaMissense
Pathogenic0.99
BayesDel_addAF
Pathogenic0.56D
BayesDel_noAF
Pathogenic0.57
CADD
Pathogenic26
DANN
Uncertain1.0
DEOGEN2
Pathogenic0.94D
Eigen
Pathogenic0.81
Eigen_PC
Pathogenic0.74
FATHMM_MKL
Pathogenic0.98D
GPN-Star LLR
N/A-7.9
GPN-Star score
N/A7.9
LIST_S2
Uncertain0.89D
M_CAP
Pathogenic0.71D
MetaRNN
Pathogenic0.99D
MetaSVM
Pathogenic1.1D
Mutation Taster
N/A0/100disease causing (ClinVar)
MutationAssessor
Uncertain2.7M
PhyloP100
Pathogenic8.1
popEVE
Benign-3.5
PrimateAI
Uncertain0.64T
PROVEAN
Pathogenic-6.2D
REVEL
Pathogenic0.98
Sift
Pathogenic0.0D
Sift4G
Uncertain0.0070D
Varity_R
N/A0.93
VESM-3B
Benign-11
Showing 27 of 27 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.